Titolo	Data di pubblicazione	Autore(i)
1	Zollinger-Ellison syndrome in 2006: concepts from a clinical point of view	2006	PELLICANO R; DE ANGELIS C; RESEGOTTI A; RIZZETTO M
2	Zafirlukast-related hepatitis: report of a further case.	2001	ACTIS GC ;MORGANDO A ;LAGGET M ;DAVID E ;RIZZETTO M
3	Virologia,patogenesi e diagnostica dell'infezione Delta	1993	Rizzetto M; Rosina F; Durazzo M
4	Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence.	2005	MARZANO A; GAIA S; GHISETTI V; CARENZI S; PREMOLI A; DEBERNARDI-VENON W; ALESSANDRIA C; FRANCHELLO A; SALIZZONI M; M. RIZZETTO
5	Validation of surrogate indexes of peripheral and hepatic insulin resistance and evaluation of their utility as non-invasive predictors of histological features in patients with Non-Alcoholic Fatty Liver Disease	2014	Chiara Rosso; Ester Vanni; Lavinia Mezzabotta; Roberto Gambino; Francesca Saba; Federico Salomone; Ramy Ibrahim Kamal Jouness; Melania Gaggini; Emma Buzzigoli; Chiara Saponaro; Fabrizia Carli; Gian Paolo Caviglia; Maria Lorena Abate; Antonina Smedile; Mario Rizzetto; Maurizio Cassader; Amalia Gastaldelli; Elisabetta Bugianesi
6	Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection: an AIGO study.	2001	A. ANDRIULLI; V. FESTA; G. LEANDRO; M. RIZZETTO
7	Use of arterial conduit as an alternative technique in arterial revascularization during orthotopic liver transplantation.	2002	ZAMBONI F ;FRANCHELLO A ;RICCHIUTI A ;FOP F ;RIZZETTO M ;SALIZZONI M
8	UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells.	2014	De Nicolò A;Agnesod D;Simiele M;Riganò D;Adriani A;Canaparo R;Astegiano M;Rizzetto M;Di Perri G;D'Avolio A
9	Updated review (2006) on Helicobacter pylori as a potential target for the therapy of ischemic heart disease	2006	PELLICANO R; PEYRE S; ASTEGIANO M; OLIARO E; FAGOONEE S; RIZZETTO M
10	Type D hepatitis: the clinical significance of hepatitis D virus RNA in serum as detected by a hybridization-based assay.	1986	SMEDILE A ;RIZZETTO M ;DENNISTON K ;BONINO F ;WELLS F ;VERME G ;CONSOLO F ;HOYER B ;PURCELL RH ;GERIN JL
11	Type 2 diabetes mellitus and chronic hepatitis C: Which is worse? Results of a long-term retrospective cohort study.	2012	Giordanino C; Ceretto S; Bo S; Smedile A; Ciancio A; Bugianesi E; Pellicano R;Fagoonee S; Versino E; Costa G; Arese D; Sacco M; Rizzetto M; Saracco G.
12	Two Combined Genetic Markers Identify Hepatitis C Recipients With a Lower Graft Survival From The Earliest Post-Transplant Period	2015	Martini, Silvia; Romagnoli, Renato; Tandoi, Francesco; Dell'Olio, Dominic; Magistroni, Paola; Bertinetto, Francesca E.; Dametto, Ennia; Mirabella, Stefano; Rizza, Giorgia; Cocchis, Donatella; Ottobrelli, Antonio; Rizzetto, Mario; Salizzoni, Mauro; Amoroso, Antonio
13	TT virus infection in Italy: prevalence and genotypes in healthy subjects, viral liver diseases and asymptomatic infections by parenterally transmitted viruses.	2001	MASIA G ;INGIANNI A ;DEMELIA L ;FAA G ;MANCONI PE ;PILLERI G ;CIANCIO A ;RIZZETTO M ;COPPOLA RC
14	Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.	1991	Craxì A; Di Marco V; Volpes R; Marra S; Rizzetto M; Rosina F; Barbera C; Bortolotti F; Crivellaro C; Iannuzzi C; et al.
15	Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.	2001	SARACCO G; CIANCIO A; GHISETTI V; ROCCA G; CARITI G; ANDREONI M; TABONE M; ROFFI L; CALLERI G; BALLARE M; TERRENI N; SARTORI M; TAPPERO GF; TRAVERSO A; POGGIO A; ORANI A; MAGGI G; DI NAPOLI A; ARRIGONI A; M. RIZZETTO
16	TREATMENT WITH INTERFERON-alfa2b OF NAIVE NON-CIRRHOTIC PATIENTS WITH CHRONIC HEPATITIS C ACCORDING TO VIRAEMIA AND GENOTYPE. RESULTS OF A RANDOMIZED MULTICENTRE STUDY	2001	Saracco, Giorgio Maria; Ciancio, Alessia; Ghisetti, V.; Rocca, G.; Cariti, G.; Androni, M.; Tabone, M.; Roffi, L.; Talleri, G.; Ballare, M.; Terreni, N.; Sartori, M.; Tappero, G. F.; Traverso, A.; Poggio, A.; Orani, A.; Maggi, G.; Di Napoli, A.; Arrigoni, A.; Rizzetto, Mario
17	TREATMENT WITH INTERFERON	1991	Saracco, Giorgio Maria; Rizzetto, Mario
18	TREATMENT OF RECURRENT HEPATITIS C VIRUS INFECTION AFTER LIVER TRANSPLANTATION	1999	LAVEZZO B; M. RIZZETTO
19	Treatment of recurrent hepatitis C in liver transplants: efficacy of a six versus a twelve month course of interferon alfa 2b with ribavirin.	2002	B. Lavezzo; A. Franchello; A. Smedile; E. David; A. Barbui; M. Torrani; A. Ottobrelli; F. Zamboni; M. Fadda; A. Bobbio; M. Salizzoni; M. Rizzetto.
20	Treatment of hepatitis D	2005	NIRO GA; ROSINA F; RIZZETTO M